With increasing economic burden associated with proliferation of cancer worldwide, radiation therapy has become a boon for the patients. Technological advancement in the field facilitates more precise and noninvasive therapies. The report ?Global Radiotherapy Market by Products (Proton Therapy, Linear Accelerator, CyberKnife, Gamma Knife and TomoTherapy)- Market Outlook 2022? provides an in-depth analysis of global radiotherapy market focusing on external beam radiation therapy products such as Proton Therapy, Linear Accelerator, CyberKnife, Gamma Knife and TomoTherapy. Market analysis of aforementioned radiotherapy products has been forecast for the period 2017-22.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities at the global and regional level. The report has been segmented as following:-
Market Segmentation by Products
? Proton Therapy
? Linear Accelerator (LINAC)
? CyberKnife
? Gamma Knife
? TomoTherapy
Key Vendors
? Varian Medical Systems
? Elekta AB
? Accuray Inc.

Economic burden of cancer has been on an increasing spree globally. Radiation oncology, chemotherapy and surgery are major approaches followed for cancer treatment globally. Radiation therapy with its ionizing radiation, precisely and accurately limits the proliferation of malignant cells, while sparing adjacent healthy tissue. Global radiation oncology market is classified into External Beam Radiation Therapy, Internal Radiation Therapy or Brachytherapy and Systemic Radioisotope Therapy. External Beam Radiation Therapy is the most popular category with products such as Proton Therapy, Linear Accelerators, Gamma Knife, CyberKnife and TomoTherarapy.
Growth of the market is driven by rise in cancer incidences globally, ageing population, replacement of installed base of devices, cost-effectiveness of radiotherapy treatment and market opportunity in emerging markets. Growth of radiotherapy in developed nations is stunted as these markets are already mature with significant installed base. Demand is expected to come from under-equipped emerging economies. Companies operating in the segment are vying for gaining market penetration in emerging economies coupled with the replacement market in developed nations. Key challenges of the industry include government regulations in the industry, high installation costs, lack of skilled medical professionals and limited reimbursement provision.
In the report, radiotherapy market assessment is done across major markets such as North America, Asia Pacific, Europe Middle East & Africa (EMEA) and Latin America. North America is the world?s largest market for radiation therapy. At present, it is characterized as a replacement market. It is followed by EMEA and Asia Pacific region at second and third position. Furthermore, market segmentation is done along major radiotherapy products prevailing in the industry. These include popular external beam radiation therapy products such as Proton Therapy, Linear Accelerators, Gamma Knife, CyberKnife and TomoTherarapy.
Global radiotherapy market is dominated by leading players such as Varian Medical Systems, Elekta AB, Accuray Inc., Siemens AG, among others. Varian Medical Systems, Elekta AB and Accuray Inc. are profiled herein based on attributes such as business overview, product segments, financial and business strategies. The report also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global radiotherapy market with specific focus on leading radiotherapy products.